|
Effect of Individualized Exercise in Elderly Patients With Coronary Heart Disease
RECRUITINGN/ASponsored by The First Affiliated Hospital with Nanjing Medical University
Actively Recruiting
PhaseN/A
SponsorThe First Affiliated Hospital with Nanjing Medical University
Started2023-10-17
Est. completion2024-12-17
Eligibility
Age60 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06588231
Summary
The benefits of cardiac rehabilitation have been supported by a large amount of evidence-based medicine. Cardiac rehabilitation can correct cardiovascular risk factors, reduce morbidity and mortality, and improve quality of life.
Eligibility
Age: 60 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria: * Coronary heart disease: coronary angiography confirmed patients with coronary heart disease. * Age is 60-75 years old, and the clinical sinus rhythm is stable. * Left ventricular ejection fraction was\> 40%. * Informed consent and voluntary participation. Exclusion Criteria: * Patients with severe organic cardiac and lung diseases. * Patients with hemiplegia and other physical action disorders. * A history of mental illness. * Uncontrolled hypertension, and hemodynamic instability. * Severe nephropathy and severe peripheral artery disease. * Patients with bone and joint diseases who are not suitable for exercise. * Uncontrolled endocrine system and other diseases. * Antibiotics and anti-diarrheal medications have not been used for at least 3 months.
Conditions2
Coronary Heart DiseaseHeart Disease
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorThe First Affiliated Hospital with Nanjing Medical University
Started2023-10-17
Est. completion2024-12-17
Eligibility
Age60 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06588231